Bradley Javorsky, MD
Associate Clinical Professor, Medicine (Endocrinology)
Internship & Residency in Internal Medicine, University of Virginia, Charlottesville, VA, 2005
MD, University of Wisconsin Medical School, Madison, WI, 2002
Dr. Javorsky is a Medical College of Wisconsin endocrinologist who sees adults for endocrine-related health concerns and management of long-term health conditions. He has a special interest in diseases of the pituitary and causes of obesity. Dr. Javorsky received his medical degree from the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin. He completed his residency in internal medicine at the University of Virginia in Charlottesville, Virginia. He stayed there for a clinical and research fellowship in endocrinology and metabolism where his research focus was on the hormonal control of appetite. He joined the faculty of the Medical College of Wisconsin in 2008.
"I believe there is a strong interplay between biology and the environment in every person's health. As a result, each patient requires an evidence-based, but individualized treatment approach."
- Lipid Disorders
- Thyroid Disorders
- Adrenal Disorders
- Diabetes Mellitus
- Endocrine Hypertension
- Thyroid Cancer
- Parathyroid and Calcium Disorder
(Carroll TB, Javorsky BR, Findling JW.) Endocr Pract. 2016 Oct;22(10):1216-1223.
Response to comments on: Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy following adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.
(Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS.) Surgery. 2016 07;160(1):249-250.
(Glenn JA, Yen TW, Javorsky BR, Rose BG, Carr AA, Doffek KM, Evans DB, Wang TS.) J Surg Res. 2016 May 01;202(1):132-8.
Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.
(Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS.) Surgery. 2016 Jan;159(1):259-65.
(Javorsky BR, Carroll TB, Tritos NA, Salvatori R, Heaney AP, Fleseriu M, Biller BM, Findling JW.) Obes Surg. 2015 Dec;25(12):2306-13.
(ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.) N Engl J Med. 2012 Jul 26;367(4):319-28.
(ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.) N Engl J Med. 2012 Jul 26;367(4):309-18.
Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study.
(Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC.) J Clin Oncol. 2000 Dec 15;18(24):4077-85.
(de Jong JL, Farner NL, Javorsky BR, Lindstrom MJ, Hank JA, Sondel PM.) Clin Cancer Res. 1998 May;4(5):1287-96.